← SynDRA
REPARIXIN
SynDRA canonical compound SYN0005797 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | CXCR2 |
| Mechanism of action | CCK receptor antagonist |
All known targets
Mechanisms of action (all sources)
- CCK receptor antagonist
- CXCR1 MODULATOR
- Interleukin-8 receptor A modulator
- CXCR2 MODULATOR
- Interleukin-8 receptor B modulator
- CC chemokine receptor antagonist
Cross-references
Synonyms
- Reparixine
- Reparixina
- DF-1681Y
- Repertaxin
- DF1681Y
- repertaxin
- UNII-U604E1NB3K
- CHEMBL191413
- U604E1NB3K
- (R)-2-(4-isobutylphenyl)-N-(methylsulfonyl)propanamide
- Reparixin [USAN:INN]
- (2R)-2-[4-(2-methylpropyl)phenyl]-N-methylsulfonylpropanamide
- (2R)-2-(4-(2-Methylpropyl)phenyl)-N-methylsulfonylpropanamide
- 2-(4-isobutylphenyl)propionylmethanesulfonamide
- Reparixin (USAN/INN)
- DSSTox_RID_81678
- DSSTox_CID_26509
- DSSTox_GSID_46509
- ZINC8717
- SCHEMBL1884299
- GTPL8498
- DTXSID6046509
- EX-A2461
- BCP10635
- Tox21_112272
- BDBM50169045
- Reparixin [INN]
- Reparixin (INN/USAN)
- (R)-2-(4-isobutylphenyl)propionylmethanesulfonamide
- RAPARIXIN
- DTXCID4026509
- reparixinum
- RefChem:879252
- Repertaxin;DF 1681Y
- Reparixin (Repertaxin)
- Reparixin?
- MFCD18633292
- REPARIXIN [USAN]
Look up REPARIXIN in the interactive SynDRA portal →